Published in Eur Heart J on February 01, 1991
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J (1991) 1.83
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA study. Cardiovasc Diabetol (2003) 0.89
Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease. Br Heart J (1994) 0.87
Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease. J Thromb Thrombolysis (1998) 0.80
Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action? Trans Am Clin Climatol Assoc (1996) 0.75
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J (1991) 1.83
High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment. Circulation (1997) 1.47
Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. J Intern Med (2011) 1.41
Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest (2008) 1.20
Autonomic cardiovascular regulation in patients with obstructive sleep apnoea: a study based on spectral analysis of heart rate variability. Clin Physiol (2000) 1.08
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord (2007) 1.07
Serum lipids, glucose and insulin levels in healthy schoolchildren aged 9 and 15 years from Central Sweden: reference values in relation to biological, social and lifestyle factors. Scand J Clin Lab Invest (2005) 1.07
D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg (2004) 1.05
Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol (1985) 1.03
Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation (1993) 1.01
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J (1989) 1.00
Preliminary study of D-dimer as a possible marker of acute bowel ischaemia. Br J Surg (2001) 0.99
Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. Atherosclerosis (1989) 0.98
Ischemic stroke. Impact of a recent myocardial infarction. Stroke (1999) 0.98
Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy. Clin Exp Immunol (1987) 0.97
Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med (2004) 0.97
Oral anticoagulant treatment in a medical care district--a descriptive study. Scand J Prim Health Care (1995) 0.96
Cardiac involvement in congenital myotonic dystrophy. Br Heart J (1990) 0.95
Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand (1980) 0.89
Echocardiographic features in familial amyloidosis with polyneuropathy. Acta Med Scand (1983) 0.89
The effect of streptokinase neutralizing antibodies on fibrinolytic activity and reperfusion following streptokinase treatment in acute myocardial infarction. J Intern Med (2002) 0.88
Endurance physical activity, diet and fibrinolysis. Atherosclerosis (1994) 0.86
Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med (1999) 0.86
Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev (2003) 0.85
The sick sinus syndrome in familial amyloidosis with polyneuropathy. Int J Cardiol (1983) 0.85
The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy. A clinico-pathologic study of six cases from Northern Sweden. Acta Pathol Microbiol Immunol Scand A (1983) 0.85
Spectral analysis of heart rate variability in patients with irritable bowel syndrome. Scand J Gastroenterol (1998) 0.84
Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J (1984) 0.84
The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden. Virchows Arch A Pathol Anat Histopathol (1984) 0.82
Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest (1985) 0.82
Pulmonary function in familial amyloidosis with polyneuropathy. Acta Med Scand (1981) 0.82
Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost (1989) 0.82
Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr (2006) 0.81
Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. Eur Heart J (1996) 0.81
Heart valve involvement in familial amyloidosis with polyneuropathy. Pathol Res Pract (1986) 0.80
Ventricular dysfunction in type 1 myotonic dystrophy: electrical, mechanical, or both? Int J Cardiol (2009) 0.80
Hypo-fibrinolysis in patients with hypertension and elevated cholesterol. J Intern Med (1991) 0.80
Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease. Int J Proteomics (2012) 0.79
Effects of partial hepatectomy on plasma fibronectin concentrations in the rat. Br J Exp Pathol (1987) 0.79
Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden. Coron Artery Dis (2001) 0.79
Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability. Acta Neurol Scand (1989) 0.79
Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study. Acta Med Scand (1988) 0.79
Thrombocytosis in active rheumatoid arthritis. Relation to other parameters of inflammatory activity and confounding effect of automated cell counting. Clin Rheumatol (1988) 0.79
Heart-rate variation: what are we measuring? Clin Physiol (1993) 0.78
Prealbumin: its association with amyloid. J Clin Pathol (1987) 0.78
Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease. J Intern Med (2005) 0.78
Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol (1983) 0.78
Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. Stroke (1998) 0.78
Folate-metabolizing gene variants and pregnancy outcome of IVF. Reprod Biomed Online (2011) 0.78
Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol (1985) 0.78
Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment. Thromb Haemost (1995) 0.78
Altered mRNA expression due to acute mesenteric ischaemia in a porcine model. Eur J Vasc Endovasc Surg (2010) 0.77
Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol. Eur J Clin Pharmacol (1991) 0.77
Hemodynamic and angiocardiographic observations in familial amyloidosis with polyneuropahy. Acta Med Scand (1982) 0.77
Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography. Acta Med Scand (1987) 0.77
Pacemaker treatment in familial amyloidosis with polyneuropathy. Pacing Clin Electrophysiol (1984) 0.77
Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals. Metabolism (1992) 0.77
Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study. Curr Med Res Opin (1993) 0.77
Prevalence of coronary artery disease in patients with valvular heart disease. Acta Med Scand (1985) 0.77
Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion. Eur J Haematol (1989) 0.77
Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. Metabolism (1998) 0.77
Plasma glucose and insulin, urinary catecholamine and cortisol responses to test breakfasts with high or low fibre content: the importance of the previous diet. Ann Nutr Metab (1989) 0.77
Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand (1986) 0.76
Assessment of autonomic nerve function in acute intermittent porphyria; a study based on spectral analysis of heart rate variability. J Intern Med (1996) 0.76
Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: an evaluation by spectral analysis of heart rate variability. J Intern Med (1997) 0.76
Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden. J Clin Epidemiol (1989) 0.76
Blood cell telomere length among patients with an isolated popliteal artery aneurysm and those with multiple aneurysm disease. Atherosclerosis (2011) 0.76
Adrenal steroid dysregulation in dystrophia myotonica. J Intern Med (1999) 0.76
Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis. Clin Rheumatol (1993) 0.76
Pyrosequencing assay for genotyping of the Transcobalamin II 776C>G polymorphism. Scand J Clin Lab Invest (2007) 0.76
Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation (1997) 0.75
Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand. Biochem J (1992) 0.75
Platelet clumping in Ph-negative myeloproliferative syndromes. Acta Med Scand (1987) 0.75
Cardiac stimulation threshold in familial amyloidosis with polyneuropathy. Pacing Clin Electrophysiol (1987) 0.75
Familial amyloidotic polyneuropathy in northern Sweden. A cross-sectional and longitudinal study of cardiac function with echocardiography. Arctic Med Res (1988) 0.75
Highly refractile myocardial echoes in familial amyloidosis with polyneuropathy. A correlative echocardiographic and histopathological study. Acta Med Scand (1985) 0.75
Cor triatriatum. Int J Cardiol (1982) 0.75
Cardiopulmonary function in sarcoidosis. Acta Med Scand (1984) 0.75
24-hour electrocardiographic study in myotonic dystrophy. Cardiology (1988) 0.75
Thrombomodulin and acute bleeding duodenal ulcer. J Intern Med (1999) 0.75
Long-term follow up of von Willebrand factor and plasminogen activator inhibitor-1 in patients with polymyalgia rheumatica. Ann Rheum Dis (1997) 0.75
The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women. Scand J Clin Lab Invest (1988) 0.75
Electrocardiographic findings in myotonic dystrophy. Arctic Med Res (1988) 0.75
Elevated plasma homocysteine: cause or consequence of myocardial infarction? J Intern Med (2004) 0.75
Production of lactate and tissue plasminogen activator in vitro by seminiferous tubules obtained from adult unilaterally cryptorchid rats. Arch Androl (1987) 0.75
Impact of acute phase on concentrations of tissue plasminogen activator and plasminogen activator inhibitor in plasma after deep-vein thrombosis or open-heart surgery. Clin Chem (1989) 0.75
Reduced levels of tissue plasminogen activator and plasminogen activator inhibitor in plasma of patients with familial amyloidotic polyneuropathy. Haemostasis (1990) 0.75
Alterations in C1 inhibitor and clotting factor concentrations in primary biliary cirrhosis and other chronic liver diseases. Scand J Gastroenterol (1990) 0.75
On the utility of assays of plasmin-alpha 2-antiplasmin complex in rheumatic and inflammatory diseases. Scand J Rheumatol (1990) 0.75
Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction. Eur J Clin Pharmacol (1993) 0.75
Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke (1999) 0.75